title: Central cardiovascular action of urotensin II in conscious rats.
abstract: OBJECTIVE
  To examine the central cardiovascular action of urotensin II in conscious rats.
  
  
  METHODS
  Intracerebroventricular (ICV) injections of urotensin II (1 and 10 nmol) were carried out in conscious Wistar rats. The effects of intravenous (i.v.) urotensin II (10 nmol) were also determined.
  
  
  RESULTS
  The ICV injection of urotensin II at a dose of 1 nmol did not alter the arterial pressure or heart rate significantly, while 10 nmol urotensin II increased the arterial pressure and heart rate. The mean arterial pressure at 5 min of ICV urotensin II was 121 +/- 4 mmHg, which was significantly higher than that obtained by ICV injection of artificial cerebrospinal fluid (107 +/- 3 mmHg, P <0.05). In addition, significant increases in heart rate were observed 5-15 min after ICV urotensin II. Pre-treatment with pentolinium (5 mg/kg, i.v.) significantly attenuated the increases in mean arterial pressure (20 +/- 3 versus 8 +/- 2 mmHg, P <0.01) and heart rate (78 +/- 18 versus 7 +/- 5 beats/min, P <0.05) induced by ICV urotensin II. On the other hand, i.v. injection of urotensin II (10 nmol) elicited a depressor response associated with tachycardia; mean arterial pressure 5 min after injection was significantly lower in the urotensin II-injected rats (89 +/- 5 mmHg) than in the control rats (102 +/- 2 mmHg, P <0.05), and the heart rate was significantly higher in the former (402 +/- 11 versus 360 +/- 9 beats/min, respectively, P <0.05).
  
  
  CONCLUSIONS
  Central urotensin II produces pressor and tachycardic responses through sympathetic activation, while peripheral urotensin II exerts a vasodilation-mediated depressor response in conscious rats.
authors.affiliation: Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan.
authors.forename: Yingzi
authors.initials: Y
authors.lastname: Lin
authors.forename: Takuya
authors.initials: T
authors.lastname: Tsuchihashi
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Matsumura
authors.forename: Isao
authors.initials: I
authors.lastname: Abe
authors.forename: Mitsuo
authors.initials: M
authors.lastname: Iida
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000502:physiology*; D002319:Cardiovascular System / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D007275:Injections, Intravenous; D007276:Injections, Intraventricular; D008297:Male; D010425:Pentolinium Tartrate / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D014579:Urotensins / Q000008:administration & dosage*
chemical_list: D000959:Antihypertensive Agents; D014579:Urotensins; C029677:urotensin II; D010425:Pentolinium Tartrate